Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

Real-Time Quote
 +0.015 / +1.06%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Sunesis Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company primarily engages in development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused primarily on the development of vosaroxin for the treatment of acute myeloid leukemia. The company's primary activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. Sunesis Pharmaceuticals was founded on February 10, 1998 and is headquartered in South San Francisco, CA.

Contact Information

Sunesis Pharmaceuticals, Inc.
395 Oyster Point Boulevard
South San Francisco California 94080
P:(650) 266-3500
Investor Relations:
(650) 266-3717



Other institutional54.51%
Mutual fund holders30.13%
Individual stakeholders16.18%

Top Executives

Daniel N. SwisherPresident, Chief Executive Officer & Director
Eric H. BjerkholtCFO, Secretary & EVP-Corporate Development
Gene C. JamiesonVice President-Technical Operations
Adam R. CraigChief Medical Officer & Executive VP-Development
Joseph I. DePintoChief Commercial Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.